Keir Amy, Pal Sanchita, Trivella Marialena, Lieberman Lani, Callum Jeannie, Shehata Nadine, Stanworth Simon J
Robinson Research Institute and the School of Medicine, University of Adelaide, Adelaide, Australia.
Rosie Neonatal Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
Transfusion. 2016 Nov;56(11):2773-2780. doi: 10.1111/trf.13785. Epub 2016 Sep 7.
Controversy exists regarding the contribution of blood transfusions to a range of adverse clinical outcomes in neonates. The aim of our systematic review was to identify the broader literature on harmful effects and associations potentially attributable to red blood cell (RBC) transfusions.
A comprehensive search of MEDLINE (PubMed) and EMBASE was undertaken. Eligible studies included both randomized controlled trials (RCTs) and nonrandomized studies examining the effects of small volume (10-20 mL/kg) RBC transfusions on neonates. Primary outcomes of interest were mortality, chronic lung disease, retinopathy of prematurity, necrotizing enterocolitis, and intraventricular hemorrhage. Two independent authors conducted a review of abstracts and then of full-text article reviews as well as data extraction and quality assessments.
Sixty-one studies were eligible for inclusion, including 16 (26%) randomized studies. The majority of studies were nonrandomized (n = 45; 74%), which included 32 observational studies with and 13 studies without a comparator group. There was no evidence that rates of mortality differed between restrictive and liberal strategies for transfusion (eight RCTs: risk ratio, 1.24; 95% confidence interval, 0.89-1.672, heterogeneity = 0%) or for necrotizing enterocolitis (five RCTs: risk ratio, 1.45; 95% confidence interval, 0.91-2.33; heterogeneity = 0%). A liberal strategy also was not superior to restrictive transfusion practice in the pooled randomized studies for rates of retinopathy of prematurity, chronic lung disease, or intraventricular hemorrhage.
Statistically significant differences in a range of harmful outcomes between neonates exposed to restrictive and liberal RBC transfusion practice were not found. However, the risks of bias identified in many studies and the lack of consistent reporting and definitions of events limits our conclusions.
关于输血对新生儿一系列不良临床结局的影响存在争议。我们系统评价的目的是确定关于红细胞(RBC)输血可能导致的有害影响及关联的更广泛文献。
对MEDLINE(PubMed)和EMBASE进行了全面检索。符合条件的研究包括随机对照试验(RCT)和非随机研究,这些研究考察了小剂量(10 - 20 mL/kg)RBC输血对新生儿的影响。感兴趣的主要结局包括死亡率、慢性肺病、早产儿视网膜病变、坏死性小肠结肠炎和脑室内出血。两名独立作者先对摘要进行了综述,然后对全文进行了综述以及数据提取和质量评估。
61项研究符合纳入标准,其中16项(26%)为随机研究。大多数研究为非随机研究(n = 45;74%),其中包括32项有对照的观察性研究和13项无对照的研究。没有证据表明输血的限制性策略和宽松策略在死亡率方面存在差异(8项RCT:风险比,1.24;95%置信区间,0.89 - 1.672,异质性 = 0%)或在坏死性小肠结肠炎方面存在差异(5项RCT:风险比,1.45;95%置信区间,0.91 - 2.33;异质性 = 0%)。在汇总的随机研究中,宽松策略在早产儿视网膜病变、慢性肺病或脑室内出血发生率方面也不优于限制性输血策略。
未发现接受限制性和宽松性RBC输血的新生儿在一系列有害结局上存在统计学显著差异。然而,许多研究中发现的偏倚风险以及事件报告和定义缺乏一致性限制了我们的结论。